Miral, Junielyn H.

HRN: 23-03-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2025
AMPICILLIN 1GM (VIAL)
12/15/2025
12/16/2025
IV
2gram
Q6
G2P1 (1001) PU 41 2/7 Weeks
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: